BOUT vs. PILL ETF Comparison
Comparison of Innovator IBD Breakout Opportunities ETF (BOUT) to Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL)
BOUT
Innovator IBD Breakout Opportunities ETF
BOUT Description
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified. BOUT uses technical analysis to find stocks that are likely to breakout. The funds index relies on an algorithm that establishes a base price (a recent high) for each eligible security. The index then follows the trend for each stock. Selected stocks are ranked by a combination of relative strength and fundamental factors, and then weighted in fixed tiers according to this ranking. In addition, BOUT will move 50% of its portfolio into T-bills based on market signals: a rapid increase in either margin debt or overall stock prices, combined with slowing reversing momentum in the S&P 500. The T-bill position will remain in place until the S&P 500 falls by 50% or show indications of rising momentum. BOUT is rebalanced and reconstituted weekly after the close on Friday. The frequent rebalance schedule means the fund will be highly responsive to the technical factors that drive its strategy, but could also experience high turnover.
Grade (RS Rating)
Last Trade
$40.14
Average Daily Volume
2,990
44
PILL
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
PILL Description
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.Grade (RS Rating)
Last Trade
$8.96
Average Daily Volume
51,627
44
Performance
| Period | BOUT | PILL |
|---|---|---|
| 30 Days | 7.95% | -4.48% |
| 60 Days | 9.94% | 6.92% |
| 90 Days | 9.81% | 10.21% |
| 12 Months | 32.83% | 67.40% |
BOUT Overweight 42 Positions Relative to PILL
| Symbol | Grade | Weight | |
|---|---|---|---|
| PACS | F | 4.48% | |
| MS | A | 4.47% | |
| LBRDK | C | 4.44% | |
| NEM | D | 4.42% | |
| VIK | B | 4.39% | |
| EXPE | B | 4.28% | |
| EQIX | A | 4.25% | |
| AHR | A | 4.24% | |
| IDCC | B | 4.01% | |
| ETN | A | 3.82% | |
| SPGI | C | 3.81% | |
| EQH | C | 3.78% | |
| CRM | B | 3.73% | |
| BAH | F | 3.73% | |
| DVA | C | 3.71% | |
| PGR | A | 3.63% | |
| CRDO | B | 2.87% | |
| VRNS | D | 2.61% | |
| ULS | B | 2.59% | |
| IR | B | 2.49% | |
| DT | D | 2.49% | |
| NMIH | C | 2.44% | |
| ONON | A | 2.35% | |
| TSM | B | 1.31% | |
| TBBK | B | 1.28% | |
| NOW | A | 1.27% | |
| CDNA | D | 1.24% | |
| SCCO | F | 1.22% | |
| SN | D | 1.2% | |
| TCOM | B | 1.14% | |
| BEKE | D | 1.06% | |
| ROAD | B | 0.45% | |
| AXON | A | 0.43% | |
| TPH | D | 0.42% | |
| IBKR | A | 0.42% | |
| CWAN | B | 0.42% | |
| AVGO | D | 0.42% | |
| ALKT | B | 0.42% | |
| GMED | A | 0.41% | |
| ACGL | C | 0.4% | |
| PLMR | A | 0.39% | |
| JD | D | 0.38% |
BOUT Underweight 42 Positions Relative to PILL
| Symbol | Grade | Weight | |
|---|---|---|---|
| BMY | B | -2.69% | |
| LBPH | A | -2.67% | |
| ITCI | C | -2.63% | |
| JAZZ | B | -2.63% | |
| VTRS | A | -2.48% | |
| AXSM | B | -2.38% | |
| EWTX | C | -2.38% | |
| CTLT | C | -2.22% | |
| ELAN | D | -2.18% | |
| PRGO | C | -2.13% | |
| RPRX | D | -2.1% | |
| JNJ | C | -2.06% | |
| ZTS | D | -2.04% | |
| PFE | F | -2.0% | |
| LLY | F | -1.98% | |
| MRK | D | -1.9% | |
| TARS | C | -1.86% | |
| ARVN | F | -1.73% | |
| OGN | F | -1.7% | |
| SAVA | C | -1.68% | |
| PBH | A | -1.6% | |
| SUPN | C | -1.46% | |
| AMPH | F | -1.39% | |
| PCRX | C | -1.27% | |
| LGND | C | -1.2% | |
| ANIP | F | -1.04% | |
| OCUL | D | -1.0% | |
| AMRX | C | -0.89% | |
| HROW | D | -0.88% | |
| HRMY | D | -0.84% | |
| WVE | C | -0.8% | |
| MNMD | C | -0.78% | |
| INVA | D | -0.67% | |
| EYPT | D | -0.65% | |
| LQDA | F | -0.61% | |
| FULC | F | -0.6% | |
| PLRX | D | -0.6% | |
| ELVN | D | -0.45% | |
| NUVB | C | -0.4% | |
| EOLS | D | -0.36% | |
| PHAT | F | -0.33% | |
| XERS | C | -0.31% |
BOUT: Top Represented Industries & Keywords
PILL: Top Represented Industries & Keywords
Compare ETFs
